Questex’s Fierce Innovation Awards – Healthcare Edition 2019 Announces Finalists, TruTag Technologies’ Mobile Phone App Recognized
Winners across five different categories will be revealed in the upcoming Innovation Report highlighting the best products, services, and innovations of the year.
EMERYVILLE, CA – November 6, 2019 – TruTag Technologies, Inc., a leading provider of product identity and quality assurance solutions, announced today that it has been selected as a finalist in this year’s Fierce Innovation Awards – Healthcare Edition, a peer-reviewed awards program from the publisher of FierceHealthcare. The competition highlights companies that demonstrated innovative solutions that have had the greatest potential to save money, engage patients, or revolutionize the industry over the past 12 months. TruTag was recognized as a finalist in the category of Digital/Mobile Health Solutions.
TruTag was selected as a finalist for its innovative, industry-leading product, the TruTag™ Mobile Phone App.
Finalists’ applications were reviewed by an exclusive panel of executives from major healthcare companies including Aveus, Change Healthcare, Hackensack Meridian Health, Consuming Health, Aspen Institute Health Innovators, Accenture Health, Proliance Surgeons, Cook Children’s Health Care System, Duncan Regional Hospital, Asprius, and GNSHealthcare. All applications were evaluated based on the following criteria: effectiveness, technical innovation, competitive advantage, financial impact, and true innovation. A full list of judges can be found at https://fiercehealthcareawards.secure-platform.com/a/page/judges
Winners will be announced in the 2019 Innovation Report set to publish by FierceHealthcare on Thursday, December 5th.
“We are honored that FierceHealthcare has recognized TruTag’s product identity solution, which is the first to offer the mass digitalization of medicines to the pharmaceutical industry. In making medicines smart and facilitating mobile phone authentication, we have the potential to offer a level of supply chain security previously unattainable,” said Michael Bartholomeusz, CEO of TruTag Technologies. “By engaging patients in the authentication process, we also have the potential to curtail the significant global challenge of counterfeit medications, a pandemic that impacts hundreds of thousands of lives annually.”
Continued Dr. Bartholomeusz, “Beyond identifying illegitimate and unauthorized product, our digital solution ushers in an unprecedented opportunity for patient communication and engagement that could have a marked impact on patient non-adherence.”
At Questex, we are passionate about driving business outcomes. We connect buyers and sellers and help both achieve their goals. We are online, on devices and live with experiential engagements. We understand the buyer’s behavior and evolving needs and connect them with the seller through continual touchpoints. From discovery through purchase and purchase through advocacy, we supply unmatched access, insight, engagement and turnkey solutions all in one place.
About TruTag Technologies
TruTag Technologies, Inc. is a leading security and technology solution provider serving businesses and governments around the world. TruTag has the most advanced precision-fabricated, cGMP nano-porous silica manufacturing operation in the world for a variety of applications and security solutions, including product identity for food, medicine, secure labels and documents. Learn more at www.TruTags.com.
©2019 All rights reserved. TRUTAG and TRUTAGS are registered trademarks of TruTag Technologies, Inc.
For further information, contact:
Senior Marketing Manager
Chief Operating Officer
TruTag Technologies, Inc.